Background: Electrocardiogram (ECG) is widely used to detect cardiac arrhythmia (CA) and 18 heart diseases. The development of deep learning modeling tools and publicly available large 19 ECG data in recent years has made accurate machine diagnosis of CA an attractive task to 20 showcase the power of artificial intelligence (AI) in clinical applications.
142 Layers and blocks are specified in rectangle boxes; "X5" indicates that five convolution neural network 143 (CNN) blocks are tandem-connected before connecting to the bidirectional recurrent neural network 144 (RNN) layer, which is a GRU layer. The output layer at bottom contains the probabilities predicted by the 145 model for each of the nine types of the CA classification. The type with the highest probability is the type 146 predicted by the model for the input ECG recording.
148
In our implementation, the CPSC2018 ECG data were processed into a matrix of three 149 elements: the first is the subject ID, the second identifies which of the ECG's 12 leads being 150 considered, and the third contains its 72,000 ECG values, which correspond to the recordings 151 taken by the maximum recording time (144 seconds) and on a frequency of 500 Hertz. We 152 padded zeroes up front for any recording that was less than the maximum time. The 476 multi-153 labeled subjects were extracted when the rest of 6,401 subjects were randomly divided into 10 154 equal parts to set up an 8-1-1 train, validation and test scheme of machine learning. The extracted 155 multi-labeled subjects were then added back to be included for the training. Our classification 156 training was carried out using categorical-cross-entropy loss function and ADAM optimizer in 157 the GPU version of TensorFlow from the Keras package [35] [36] [37] . Models were evaluated on their 158 performance on the validation set for 100 training epochs (an epoch refers to one cycle through 159 the full training dataset in artificial neural network learning). The best model, the one with the 160 smallest loss on the validation set, was further evaluated by computing its F1-score on the test set.
161
The procedure was repeated 10 times to complete the 10-fold training and validation plus test to 162 produce 10 best validation models. The median F1-score for each CA label, including the normal 163 type, for the 10 test sets was calculated using the F1-score package from Scikit-learn [38] . 164 We further investigated the performance of using only single lead data. To do that, for a 165 given lead we simply assigned zero to all the ECG values of the other 11 leads and derived the 166 model using the same network architecture and the same 10-fold cross validation plus test 167 procedure described above. This resulted in 120 best single-lead validation models and a median 168 F1-score for each of the 12 single leads on each of the nine CA labels. To compete for CPSC2018, the 130 best validation models (10 from full-lead training and 170 120 from single-lead training) were combined into one ensemble model by which the average of 171 the output probabilities from the 130 models for each CA type was adjusted by a weight vector 172 to produce the final probability for that CA type. The weights of the vector were optimized by 173 genetic algorithm [39] to produce the best overall median F1-score on the 10 test sets. Given an 174 input of an ECG recording, the CA type receiving the largest probability from the ensemble 175 model would then be the type of CA predicted for that ECG recording. The ensemble model was 176 our model submitted to CPSC2018, its performances on the hidden test set (2954 recordings) as 177 computed and reported by CPSC2018 organizers are presented in Table 1 .
178

Results
180
(1) Best validation models on 10-fold tests and ensemble model on hidden test 181 In Table 1 , for each CA type the median accuracy, AUC (area under the receiver operating 182 characteristic curve) and F1-score for the ten 10-fold tests from the best validation models are 183 compared with those of the ensemble model, as well as with the F1-score of the ensemble model 184 on the hidden test set of CPSC2018. The comparisons show that the ensemble model performed 185 somewhat better than the best validation models, which is expected because the former combined 186 and optimized the latter to produce the best 10-fold test results (see Methods). In addition, the 187 ensemble model's performance was quite stable across all CA types going from the publicly 188 available data to the hidden test data, reflecting the fairly similar compositions of the two sets of 189 data, as mentioned above. normal type, was observed in all other top-performing models of CPSC2018 (S1 Table) . Indeed, 202 almost all the top models produced very high F1-scores (> 0.9) for AF and bundle branch blocks.
203
Our model had significantly better predictions than the other models on several CA types, 204 especially PAC, PVC, STD, and STE. This explained how we outperformed others (S1 Table) . It
205
should be noted that all top models performed well (overall F1-score > 0.8) and the difference 206 between our model and the second-place model was minimal (S1 Table) .
207
(2) Concurrent CA types 208 One reason for models to perform less accurately on certain CA types is that for some 209 patients multiple CA types are predicted with almost equal probabilities. Fig 2 displays the 210 probabilities output by the best validation models for ECG subjects when they were in the test 211 fold of the10-fold tests. As may be seen, Normal, STD and STE are three types lacking a 212 probability score that can make them stand out from the other eight types, in consistence with the 213 model's performance results presented in Table 1 . Further analysis on model probabilities 214 showed that for many AF patients, a common concurrent CA was RBBB, while many RBBB 215 patients were often concurrent with PAC and PVC, in addition to AF (Fig 2) . These probability 216 results of concurrent CAs agreed well with the statistics of the 476 multi-labeled subjects:
217 Namely, the three most multi-labeled incidences in these subjects are AF/RBBB, RBBB/PAC 218 12 and RBBB/PVC (Table 2 ). An ensemble model without these 476 multi-labeled subjects being 219 added back to the training set (see Materials and Methods) performed well in predicting these 220 multiple CA labels (S3 Table and The performances for the best validation models using the 12-lead data in Table 1 were largely 237 replicated by those using only single-lead data. In most cases, only minimal changes of F1-scores 238 for the classification of individual CA types were noted between the analysis of 12-lead and 239 15 single-lead ECGs. The results also indicate aVR was one of the best-performing single leads, as 240 its performance ranked first in overall average and three individual CA types (Normal, AF and 241 STD), and also within top 3 in all CA types except STE and PAC. Another well-performing 242 single lead is lead V1, which ranked first in three types (I-AVB, RBBB and PAC), but did worse 243 than most other leads in some types. In comparison, lead I, which was used by Apple Watch
244
[43] , wasn't as remarkable in our tests. Lead II, the favorite of the 12 leads by physicians to take 245 a quick look at an ECG recording due to its clearest signal [44] , ranked fifth in the overall 246 average but was statistically no different from the leading leads (p value of paired t-test < 0.05).
247
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